OWL Metabolomics

🧬 Discover at INASL 2024 from August 7-10 to explore our poster presentation titled "One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population" using the OWLiver test. This innovative approach aims to improve the accuracy and ease of diagnosing these conditions, offering significant benefits for patient care and management. Our test demonstrates high sensitivity (86.1%) and positive predictive value (85.3%) for detecting MASH. The OWLiver Panel shows reliable accuracy in identifying MASH and significant fibrosis among high-risk individuals. This advancement in non-invasive diagnostics can revolutionize how we approach liver health and patient care.🔬 🗣️ Don't miss this opportunity to learn more about how our work can impact liver health and the future of medical diagnostics during the oral presentation of the poster on the Session - Special Interest Group (SIG) – MASLD the 9th August from 8:00 AM – 8.50 AM in Hall – 1. #INASL2024 #LiverHealth #Metabolomics #MedicalInnovation #Healthcare

🧪 We are thrilled to announce that OWL Metabolomics has contributed to a groundbreaking study published in the United European Gastroenterology Journal! 🧬 In collaboration with Dr. Paula Iruzubieta, Dr. Javier Crespo, and researchers from 7 Spanish hospitals, our scientific team has made significant strides in the field of hepatology. The study, titled "One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis (MASH) and fibrosis in high‐risk population," highlights the effectiveness of our OWLiver Panel, which includes the innovative MASEF Score. This blood-based test has demonstrated high accuracy and performance, offering a powerful tool for diagnosing MASH and liver fibrosis, particularly in high-risk populations. Discover more about this important research and its potential impact on liver disease diagnosis. 🔗Read the full study here: https://lnkd.in/dTCXmNTG #Hepatology #Metabolomics #LiverHealth #MedicalResearch #OWLMetabolomics #HealthcareInnovation

We are present at the INASL 2024 Congress! From August 7-10, check out our poster "One‐step non‐invasive diagnosis of metabolic dysfunction associated steatohepatitis and fibrosis in high‐risk population" presented on the one-step diagnosis using the OWLiver test. This is a fantastic opportunity for Indian physicians attending the congress to learn more about our innovative diagnostic tool. We are eager to start validation with the Indian population shortly. #Metabolomics #LiverHealth #INASL2024 #MedicalInnovation #Healthcare 🔗 Learn more about OWLiver today: https://bit.ly/4fo21RB

We are thrilled to announce our participation at the #INASL2024 Congress! From August 7-10, we will be presenting a poster on the one-step diagnosis using the OWLiver test. This event is a fantastic opportunity for Indian physicians attending the congress to learn more about our innovative diagnostic tool. We are eager to begin validation with the Indian population shortly. For additional information about OWLiver, please access the link in the comments. #Metabolomics #LiverHealth #INASL2024 #MedicalInnovation #Healthcare

¡Hoy damos la bienvenida a nuevos BAICers! 🌟 Muy felices de anunciar que Lanalden, E Process Med y OWL Metabolomics se han unido a la familia de BAIC. Su incorporación representa un fortalecimiento significativo del tejido de la Inteligencia Artificial en Euskadi y confiamos en que, con su apoyo, avanzaremos aún más en la creación de un ecosistema de Inteligencia Artificial vibrante y competitivo. ¡Bienvenidos a bordo, Lanalden, E-process Med y Owl Metabolomic! 🚀                                            --  Gaur ongietorria emango diegu BAICers berriei! 🌟 Oso pozik gaude Lanalden, E-process Med eta Owl Metabolomics BAICen familiara elkartu direla iragartzeagatik. Hiru enpresa horiek sartzeak Euskadin adimen artifizialaren ehuna nabarmen indartzea dakar, eta espero dugu, haren laguntzarekin, are gehiago aurreratuko dugula adimen artifizial dardarkari eta lehiakorreko ekosistema bat sortzen. Ongi etorri, Lanalden, E-process Med eta Owl Metabolomic!🚀 #BAICers #InteligenciaArtificial #Innovación #BAIC

🤖 OWL Metabolomics is proud to be a BAIC - Basque Artificial Intelligence Center member! 📊As part of the Basque Artificial Intelligence Center community (BAIC - Basque Artificial Intelligence Center), we are committed to leveraging artificial intelligence to enhance business competitiveness and improve the well-being of corporate citizens, governments, and people that are part of our society through emerging technologies and data science. 🌐 We are excited to collaborate with #BAIC and other innovative members to drive advancements in bioinformatics, AI, and digital transformation. We will also focus on areas such as data strategy, which #BAIC actively promotes, and applied AI across all fields and scales. Together, let's continue to push the boundaries of what's possible with deep learning and machine learning. #Bioinformatics #AI #DigitalTransformation #OWLMetabolomics #DataStrategy #AppliedAI

Happy Summer to Everyone! 🌞 We wish an excellent summer to our incredible suppliers, dedicated partners, hardworking employees, supportive stakeholders, and our entire vibrant community. May this season bring you joy, relaxation, and wonderful memories! 🏖️ Rest assured, we will continue our activity this summer. #OWLMetabolomics #HealthForAll #HappySummer

☀️ At OWL Metabolomics, we embrace the summer season starting, with a change in our work schedule for August. To make the most of the summer days, we will be transitioning to intensive workdays. We pride ourselves to prioritize wellness, happiness, and work-life balance for our workforce. We want our employees to enjoy the summer and have a good work-life balance because we care for your happiness. 🌞 Let's make this summer productive and enjoyable!

At OWL Metabolomics our expertise in #MASLD and #MASH drives our innovative approach, exemplified by our OWLiver Panel. OWLiver, a non-invasive diagnostic tool, leverages UHPLC-MS technology to analyze fasting blood samples and detect lipid biomarkers essential for liver health assessment. This innovative tool offers critical insights into liver health, aiding in the management of related metabolic disorders. We're excited to announce that OWLiver is now available in the United States through our partners, CIMA Sciences, LLC and Luxor Scientific.This expansion brings our revolutionary diagnostic tool closer to you, providing comprehensive liver health insights and enhancing patient care. Discover the impact of OWLiver and see how we're transforming liver health assessment with our pioneering non-invasive diagnostics. Step into the future of liver health with OWLiver at OWL Metabolomics. #LuxorScientific #CIMASciences #OWLMetabolomics #OWLIVER #LiverHealth #ActNowScreenToday #NASH #MASH #NAFLD #MASLD #LiverCommunity #PatientCare #LiverStrong #NoninvasiveTesting

📊 Ready to enhance your data modeling and validation skills? Dive into crucial strategies in our latest chapter, "Modeling and Data Validation," from our esteemed eBook series "Data Science Workflow Management." 📘 Uncover the essential techniques for robust data modeling and validation that are critical for effective decision-making. This chapter provides valuable insights into: 🔵 Developing accurate and reliable models. 🟠 Implementing rigorous data validation practices. 🔵 Ensuring the integrity and accuracy of your data. 🟠 Utilizing tools and techniques for model training, selection, and evaluation. 🚀 Elevate your data science projects with these expert strategies! 📥 Read your FREE chapter now! Find the access link in the comments. Boost your research, meet your goals, and lead new discoveries. #DataScience #DataModeling #DataValidation #MachineLearning #ModelTraining #ModelEvaluation